Notably, the contribution of MAPK/ERK-ZEB1 signaling pathway to multidrug resistance has been reported in numerous types of cancer, including breast cancer49, hepatocellular carcinoma50, and glioblastoma51. The gene discussed is MAPK1; the disease is cancer.